Original Research

Published on 08 Sep 2023

Clinicopathological analysis of diffuse large B-cell lymphoma using molecular biomarkers: a retrospective analysis from 7 Hungarian centers

in Hematologic Malignancies

Anett Balikó
Zsolt Szakács
Béla Kajtár
Zsombor Ritter
Attila Gyenesei
Nelli Farkas
László Kereskai
István Vályi-Nagy
Hussain Alizadeh
László Pajor

Frontiers in Oncology

doi 10.3389/fonc.2023.1224733

1,667 views

Case Report

Published on 07 Sep 2023

Case Report: ASXL1, RUNX1, and IDH1 mutation in tyrosine kinase-independent resistant chronic myeloid leukemia progressing to chronic myelomonocytic leukemia-like accelerated phase

in Hematologic Malignancies

Emmanuella Oyogoa
Lukas Streich
Philipp W. Raess
Theodore Braun

Frontiers in Oncology

doi 10.3389/fonc.2023.1217153

1,531 views
1 citation

Mini Review

Published on 06 Sep 2023

Cancer-associated fibroblasts in hematologic malignancies: elucidating roles and spotlighting therapeutic targets

in Hematologic Malignancies

Ziyang Ding
Run Shi
Weikang Hu
Lei Tian
Rong Sun
Yang Wu
Xiaoyan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1193978

2,955 views
3 citations

Original Research

Published on 31 Aug 2023

Genes selection using deep learning and explainable artificial intelligence for chronic lymphocytic leukemia predicting the need and time to therapy

in Hematologic Malignancies

Fortunato Morabito
Carlo Adornetto
Paola Monti
Adriana Amaro
Francesco Reggiani
Monica Colombo
Yissel Rodriguez-Aldana
Giovanni Tripepi
Graziella D’Arrigo
Claudia Vener

Frontiers in Oncology

doi 10.3389/fonc.2023.1198992

3,624 views
4 citations

Editorial

Published on 30 Aug 2023

Editorial: The molecular landscape and promising therapeutic targets in aggressive B-cell non-Hodgkin lymphomas

in Hematologic Malignancies

Hanno Maximilian Witte
Axel Künstner
Emil Chteinberg
Francesco Piazza
Gaël Roué
Niklas Gebauer

Frontiers in Oncology

doi 10.3389/fonc.2023.1278169

1,086 views

Review

Published on 30 Aug 2023

Autologous, allogeneic hematopoietic cell transplantation and CAR-T/NK therapy: what is their real importance in PTCL?

in Hematologic Malignancies

Samuel C. F. Couto
Ariel Kowes
Camila S. Aurabi
Theo G. M. Oliveira
Paulo Klinger
Vanderson Rocha

Frontiers in Oncology

doi 10.3389/fonc.2023.1195759

3,753 views
1 citation

Case Report

Published on 28 Aug 2023

Intravitreal methotrexate in type B lymphoblastic leukemia—Case Report

in Hematologic Malignancies

Maria Isabel Maya Naranjo
Sebastián Vallejo López
Sara Mesa Mesa
Mónica Ortiz Pérez
Mariana López Posada
Martha Lía Gaviria Bravo
María Elena González Alviar

Frontiers in Oncology

doi 10.3389/fonc.2023.1237204

1,719 views

Original Research

Published on 28 Aug 2023

Establishment of a primary renal lymphoma model and its clinical relevance

in Hematologic Malignancies

Xiaoxi Li
Minyao Deng
Chenxiao Zhang
Lingli Luo
Hui Qian

Frontiers in Oncology

doi 10.3389/fonc.2023.1089187

1,753 views
4 citations

Review

Published on 28 Aug 2023

Fifty years of BMT: risk stratification, donor matching, and stem cell collection for transplantation

in Hematologic Malignancies

Amandeep Salhotra
Shan Yuan
Haris Ali

Frontiers in Oncology

doi 10.3389/fonc.2023.1196564

4,063 views
1 citation

Original Research

Published on 22 Aug 2023

Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation

in Hematologic Malignancies

Seok Jin Kim
Jae-Cheol Jo
Dok Hyun Yoon
Deok-Hwan Yang
Sang Eun Yoon
Gyeong-Won Lee
Jee Hyun Kong
Yong Park
Ka-Won Kang
Ho-Sup Lee

Frontiers in Oncology

doi 10.3389/fonc.2023.1230629

2,343 views
1 citation

Correction

Published on 21 Aug 2023

Corrigendum: High expression level of the FTH1 gene is associated with poor prognosis in children with non-M3 acute myeloid leukemia

in Hematologic Malignancies

Junlin Zhang
Liying Liu
Jinshuang Wei
Xiaojing Wu
Jianming Luo
Hongying Wei
Liao Ning
Yunyan He

Frontiers in Oncology

doi 10.3389/fonc.2023.1212991

1,033 views

Original Research

Published on 21 Aug 2023

The molecular profile in patients with polycythemia vera and essential thrombocythemia is dynamic and correlates with disease’s phenotype

in Hematologic Malignancies

Patryk Sobieralski
Bartosz Wasąg
Aleksandra Leszczyńska
Monika Żuk
Maria Bieniaszewska

Frontiers in Oncology

doi 10.3389/fonc.2023.1224590

2,649 views
1 citation

Editorial

Published on 21 Aug 2023

Editorial: Case reports in hematological malignancies: 2022

in Hematologic Malignancies

Ahmad Antar
Arpad Szallasi
Osamu Imataki

Frontiers in Oncology

doi 10.3389/fonc.2023.1272547

1,653 views

Editorial

Published on 21 Aug 2023

Editorial: Genetic/epigenetic mechanisms and related clinical strategy in leukemia

in Hematologic Malignancies

Yonghui Li
Liping Dou
Clara Nervi

Frontiers in Oncology

doi 10.3389/fonc.2023.1275992

836 views

Original Research

Published on 18 Aug 2023

ICOS and OX40 tandem co-stimulation enhances CAR T-cell cytotoxicity and promotes T-cell persistence phenotype

in Hematologic Malignancies

Eider Moreno-Cortes
Pedro Franco-Fuquen
Juan E. Garcia-Robledo
Jose Forero
Natalie Booth
Januario E. Castro

Frontiers in Oncology

doi 10.3389/fonc.2023.1200914

4,723 views
7 citations

Original Research

Published on 18 Aug 2023

Effectiveness of chemotherapy using bortezomib combined with homoharringtonine and cytarabine in refractory or relapsed acute myeloid leukemia: a phase II, multicenter, prospective clinical trial

in Hematologic Malignancies

Chengtao Zhang
Da Gao
Xiaohong Wang
Xiuli Sun
Yan Yan
Yan Yang
Jingjing Zhang
Jinsong Yan

Frontiers in Oncology

doi 10.3389/fonc.2023.1142449

2,055 views
1 citation

Navigation group

Articles

Clinicopathological analysis of diffuse large B-cell lymphoma using molecular biomarkers: a retrospective analysis from 7 Hungarian centers

Case Report: ASXL1, RUNX1, and IDH1 mutation in tyrosine kinase-independent resistant chronic myeloid leukemia progressing to chronic myelomonocytic leukemia-like accelerated phase

Cancer-associated fibroblasts in hematologic malignancies: elucidating roles and spotlighting therapeutic targets

Genes selection using deep learning and explainable artificial intelligence for chronic lymphocytic leukemia predicting the need and time to therapy

Editorial: The molecular landscape and promising therapeutic targets in aggressive B-cell non-Hodgkin lymphomas

Autologous, allogeneic hematopoietic cell transplantation and CAR-T/NK therapy: what is their real importance in PTCL?

Intravitreal methotrexate in type B lymphoblastic leukemia—Case Report

Establishment of a primary renal lymphoma model and its clinical relevance

Fifty years of BMT: risk stratification, donor matching, and stem cell collection for transplantation

Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation

Corrigendum: High expression level of the FTH1 gene is associated with poor prognosis in children with non-M3 acute myeloid leukemia

The molecular profile in patients with polycythemia vera and essential thrombocythemia is dynamic and correlates with disease’s phenotype

Editorial: Case reports in hematological malignancies: 2022

Editorial: Genetic/epigenetic mechanisms and related clinical strategy in leukemia

ICOS and OX40 tandem co-stimulation enhances CAR T-cell cytotoxicity and promotes T-cell persistence phenotype

Effectiveness of chemotherapy using bortezomib combined with homoharringtonine and cytarabine in refractory or relapsed acute myeloid leukemia: a phase II, multicenter, prospective clinical trial